RS Medical
https://www.rsmedical.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From RS Medical
Finance Watch: October Begins With A VC Mega-Round For Newly Named Iambic
Private Company Edition: Iambic, formerly known as Entos, closed a $100m series B venture capital round to advance its AI-discovered therapeutics. Also, Evozyne raised $81m and Acesion brought in €45m in series B rounds, while Mogrify added $10m to bring its series A to $46m.
Deal Watch: Seagen Ups Presence In HER2-Positive Cancer Field With RemeGen Deal
Lilly partners with Kumquat to discover small molecule IO drug. Kite, Appia Bio collaborate on allogeneic cell therapies. AstraZeneca and Regeneron pursue novel metabolic therapies targeting GPR75. Lexeo and Stelios merge to focus on gene therapies for rare cardiovascular indications.
Bone Growth Devices To Move To Lower-Risk Regulatory Status
Under a new proposal, non-invasive bone growth stimulators could be cleared for market via the 510(k) process instead of requiring PMA scrutiny.
Asia Spotlight: Emerging Markets At Stake As Viehbacher Departs Sanofi?
As emerging markets represent 32% of Sanofi
’s overall sales, the highest among big pharma firms, will the sudden departure of Viehbacher leave a dent in one of the firm’s key growth platforms?
Company Information
- Industry
- Services
-
Services
- Managed Care, Insurance, Integrated Systems
- Outcomes Studies
- Services sold to health care facilities
- Specialized outpatient services
- Utilization Review, Claims Processing, Cost Contai
-
Managed Care, Insurance, Integrated Systems
- Specialized Provider Networks
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice